2019 European recommendations on sarcopenia diagnosis


  • N.I. Dzerovych MD, PhD, Leading Research Fellow at the Department of clinical physiology and pathology of locomotor apparatus, State Institution “D.F. Chebotarev Institute of Gerontology of the NAMS of Ukraine”, Kyiv, Ukraine; e-mail: zeronat@ukr.net http://orcid.org/0000-0002-4278-972X




sarcopenia, diagnosis, recommendations


Today, in the field of geriatric conditions, a lot of attention is paid to the study of sarcopenia. This is explained by the significant medical and social consequences of this disease. In 2010, European Working Group on Sarcopenia in Older People (EWGSOP) published its first consensus on the diagnosis of sarcopenia, presenting the first definition and diagnostic criteria of this disease. In 2016, the diagnosis of sarcopenia was officially inclu­ded in the supplemented 10th international classification of disea­ses under the code of M 62.84. Over the recent decade, many stu­dies on sarcopenia have been conducted in the world, which has led the EWGSOP representatives to revise the exis­ting definitions and criteria for sarcopenia in 2018, and thus, the se­cond consensus on the diagnosis of sarcopenia was published in 2019. The article presents epidemiological data, updated definition of sarcopenia, modern cutoff points of its diagnosis, Find-Assess-Confirm-Severity (F-A-C-S) algorithm for the diagnosis of sarcopenia.


Download data is not yet available.


Lesnyak O, Nauroy L, et all, authors; Stenmark J, editor. The Eastern European & Central Asian Regional Audit Epide-miology, costs & burden of osteoporosis in 2010. International Osteoporosis Foundation; 2010. 61 р.

Barrett-Cornor E, Weiss TW, McHorney CA, Miller PD, Siris ES. Predictors of falls among postmenopausal women: re-sults from the National Osteoporosis Risk Assessment. Osteoporos Int. 2009 May;20(5):715-22. https://doi.org/10.1007/s00198-008-0748-2.

Cruz-Jentoft AJ, Landi F, Topinková E, Michel JP. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010 Jan;13(1):1-7. https://doi.org/10.1097/MCO.0b013e328333c1c1.

Di Monaco M, Vallero F, Di Monaco R, Tappero R. Prevalence of sarcopenia and its association with osteoporosis in 313 older women following a hip fracture. Arch Gerontol Geriatr. 2011 Jan-Feb;52(1):71-4. https://doi.org/10.1016/j.archger.2010.02.002.

Landi F, Cruz-Jentoft AJ, Liperoti R, et al. Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing. 2013 Mar;42(2):203-9. https://doi.org/10.1093/ageing/afs194.

Morley JE, von Haehling S, Anker SD, Vellas B. From sarcopenia to frailty: a road less traveled. J Cachexia Sarcopenia Muscle. 2014 Mar;5(1):5-8. https://doi.org/10.1007/s13539-014-0132-3.

Davuzov PP, Kakeev BA, Sabirov IS, et al. Sarcopenic syndrome: a modern view of the problem (Literature review). Bulletin of KRSU. 2018;18(2):104-8. (in Russian).

Dodds RM, Granic A, Davies K, et al. Prevalence and incidence of sarcopenia in the very old: findings from the Newcas-tle 85+ Study. J Cachexia Sarcopenia Muscle. 2017;8(2):229-237. https://doi.org/10.1002/jcsm.12157.

Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2016;7(3):290-298. https://doi.org/10.1002/jcsm.12073.

Kim JH, Lim S, Choi SH, et al. Sarcopenia: an independent predictor of mortality in community-dwelling older Korean men. J Gerontol A Biol Sci Med Sci. 2014;69(10):1244-1252. https://doi.org/10.1093/gerona/glu050.

Patel HP, Al-Shanti N, Davies LC, et al. Lean mass, muscle strength and gene expression in community dwelling older men: findings from the Hertfordshire sarcopenia study (HSS). Calcif Tissue Int. 2014;95(4):308-316. https://doi.org/10.1007/s00223-014-9894-z.

Yamada M, Nishiguchi S, Fukutani N, et al. Prevalence of sarcopenia in community-dwelling Japanese older adults. J Am Med Dir Assoc. 2013;14(12):911-915. https://doi.org/10.1016/j.jamda.2013.08.015.

Legrand D, Vaes B, Matheп C, et al. The prevalence of sarcopenia in very old individuals according to the European consensusdefinition: insights from the BELFRAIL study. Age Ageing. 2013;42(6):727-734. https://doi.org/10.1093/ageing/aft128.

Landi F, Liperoti R, Fusco D, et al. Prevalence and risk factors of sarcopenia among nursing home older residents. J Ger-ontol A Biol Sci Med Sci. 2012;67(1):48-55. https://doi.org/10.1093/gerona/glr035.

Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Age-ing. 2019 Jan 1;48(1):16-31. https://doi.org/10.1093/ageing/afy169.

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010 Jul;39(4):412-23. https://doi.org/10.1093/ageing/afq034.

Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle. 2016 Dec;7(5):512-514. https://doi.org/10.1002/jcsm.12147.

Dodds RM, Syddall HE, Cooper R, et al. Grip strength across the life course: normative data from twelve British studies. PLoS One. 2014;9(12):e113637. https://doi.org/10.1371/journal.pone.0113637.

Cesari M, Kritchevsky SB, Newman AB, et al. Added value of physical performance measures in predicting adverse healthrelated events: results from the Health, Aging And Body Composition Study. J Am Geriatr Soc. 2009;57(2):251-9. https://doi.org/10.1111/j.1532-5415.2008.02126.x.

Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recom-mendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547-58. https://doi.org/10.1093/gerona/glu010.

Gould H, Brennan SL, Kotowicz MA, Nicholson GC, Pasco JA. Total and appendicular lean mass reference ranges for Australian men and women: the Geelong osteoporosis study. Calcif Tissue Int. 2014;94(4):363-72. https://doi.org/10.1007/s00223-013-9830-7.

Studenski S, Perera S, Patel K, et al. Gait speed and survival in older adults. JAMA. 2011;305(1):50-8. https://doi.org/10.1001/jama.2010.1923.

Pavasini R, Guralnik J, Brown JC, et al. Short physical performance battery and all-cause mortality: systematic review and meta-analysis. BMC Med 2016;14(1):215. https://doi.org/10.1186/s12916-016-0763-7.

Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995;332(9):556-61. https://doi.org/10.1056/NEJM199503023320902.

Bischoff HA, Stahelin HB, Monsch AU, et al. Identifying a cut-off point for normal mobility: a comparison of the timed ‘up and go’ test in community-dwelling and institutionalised elderly women. Age Ageing. 2003 May;32(3):315-20. https://doi.org/10.1093/ageing/32.3.315.

Newman AB, Simonsick EM, Naydeck BL et al. Association of long-distance corridor walk performance with mortality, cardiovascular disease, mobility limitation, and disability. JAMA 2006;295(17):2018-26. https://doi.org/10.1001/jama.295.17.2018.

Povoroznyuk V, Binkley N, Dzerovych N, Povoroznyuk R. Sarkopeniya [Sarcopenia]. Kyiv; 2016. 180 p. (in Ukrainian).




How to Cite

Dzerovych, N. (2021). 2019 European recommendations on sarcopenia diagnosis. PAIN, JOINTS, SPINE, 9(4), 257–261. https://doi.org/10.22141/2224-1507.9.4.2019.191925




Most read articles by the same author(s)

1 2 > >>